Keshlata Cancer Hospital Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.22 Cr
as on 23-10-2024
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.27 M
as on 23-10-2024
- Revenue 10.60%
(FY 2023)
- Profit 53.00%
(FY 2023)
- Ebitda -1.69%
(FY 2023)
- Net Worth 10.80%
(FY 2023)
- Total Assets 0.26%
(FY 2023)
About Keshlata Cancer Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 2.22 Cr.
The company has closed loans amounting to ₹3.27 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Varun Agarwal, Gopal Agarwal, and Keshav Agarwal serve as directors at the Company.
- CIN/LLPIN
U85110UP1988PLC010332
- Company No.
010332
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Dec 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationUttar Pradesh, Uttar Pradesh
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Keshlata Cancer Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Keshav Agarwal  | Managing Director | 28-Dec-1988 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varun Agarwal | Director | 27-Aug-2020 | Current |
| Gopal Agarwal | Director | 28-Dec-1988 | Current |
Financial Performance and Corporate Structure Insights of Keshlata Cancer Hospital.
Keshlata Cancer Hospital Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.6% increase. The company also saw a substantial improvement in profitability, with a 53% increase in profit. The company's net worth Soared by an impressive increase of 10.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Keshlata Cancer Hospital?
In 2023, Keshlata Cancer Hospital had a promoter holding of 96.29% and a public holding of 3.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Pradeshiya Industrial Bank Ltd. Creation Date: 04 Aug 1990 | ₹3.27 M | Satisfied |
How Many Employees Work at Keshlata Cancer Hospital?
Keshlata Cancer Hospital has a workforce of 38 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Keshlata Cancer Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Keshlata Cancer Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
